Bio-Rad Laboratories annual shares outstanding
2022
2023
2024
2025
Bio-Rad Laboratories Shares Outstanding History (BIO)
Bio-Rad Laboratories reported 27.0M shares outstanding at the end of fiscal 2025.
View full Bio-Rad Laboratories company overviewBio-Rad Laboratories annual shares outstanding history
| Fiscal year | Period ended | Shares outstanding | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 27.0M | −1.0M | −3.64% |
| 2024 | 2024-12-31 | 28.0M | −507,292 | −1.78% |
| 2023 | 2023-12-31 | 28.5M | −1.1M | −3.64% |
| 2022 | 2022-12-31 | 29.6M | — | — |
Bio-Rad Laboratories quarterly shares outstanding
Q2.10
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Shares outstanding | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | 26.7M | −324,217 | −1.20% |
| Q1 2026 | 2026-03-31 | 26.8M | — | — |
| Q4 2025 | 2025-12-31 | 27.0M | — | — |
| Q3 2025 | 2025-09-30 | 27.0M | — | — |
| Q2 2025 | 2025-06-30 | 27.1M | — | — |
| Q2 2010 | 2010-06-30 | 27.7M | — | — |
Bio-Rad Laboratories Share Buyback History
A share buyback, also called a stock repurchase, is when a company uses cash to buy its own shares. Bio-Rad Laboratories share buyback history shows the reported cash used for repurchases. Buybacks can reduce shares outstanding, but issuance, stock-based compensation, acquisitions, and stock splits can change the share count separately.
Bio-Rad Laboratories used $295.5M to repurchase common stock in fy 2025. Across the latest 5 reported fiscal years, total share repurchases were $1.19B. The latest reported quarter showed $31.5M of share repurchases.
| Fiscal year | Period ended | Share repurchases |
|---|---|---|
| 2025 | 2025-12-31 | $295.5M |
| 2024 | 2024-12-31 | $203.6M |
| 2023 | 2023-12-31 | $428.7M |
| 2022 | 2022-12-31 | $215.7M |
| 2021 | 2021-12-31 | $50.0M |
| 2020 | 2020-12-31 | $100.0M |
| 2019 | 2019-12-31 | $28.0M |
| 2018 | 2018-12-31 | $48.9M |
| 2017 | 2017-12-31 | $2.9M |
| 2016 | 2016-12-31 | $0 |
TickerStat uses SEC-reported cash payments for common-stock repurchases. The amounts describe capital returned through buybacks; they are not a forecast or a measure of the number of shares retired.
Bio-Rad Laboratories shares outstanding trends
Between the periods ended 2022-12-31 and 2025-12-31, Bio-Rad Laboratories's shares outstanding moved from 29.6M to 27.0M, a change of −2.6M. The latest reported quarter, Q2 2026, shows 26.7M.
About the metric
What shares outstanding means
Shares outstanding is the number of common shares held by investors at a reporting-period end. The count can change because of stock issuance, repurchases, conversions, acquisitions, or stock splits.
Calculation and source
SEC-reported period-end shares
TickerStat displays period-end common shares from SEC filings and adjusts older values to the current share basis when a stock-split conversion ratio is reported directly or evidenced by a later filing’s restated historical share balance. After repeated reverse splits, an old period can represent less than one current-basis share; this is a split-adjusted equivalent, not a literal historical certificate count. Values remain as reported when no reliable split ratio is available. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Bio-Rad Laboratories source filings ↗